Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Perrigo
PRGO
|
+$659M |
| 2 |
Merck
MRK
|
+$636M |
| 3 |
Las Vegas Sands
LVS
|
+$380M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$375M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$296M |
Top Sells
| 1 |
Ralph Lauren
RL
|
+$518M |
| 2 |
eBay
EBAY
|
+$474M |
| 3 |
Estee Lauder
EL
|
+$419M |
| 4 |
Goldman Sachs
GS
|
+$314M |
| 5 |
TechnipFMC
FTI
|
+$313M |
Sector Composition
| 1 | Healthcare | 20.08% |
| 2 | Consumer Discretionary | 13.88% |
| 3 | Communication Services | 10.65% |
| 4 | Technology | 10.56% |
| 5 | Energy | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Macy's
M
$4.56B
| $3.71M | ﹤0.01% |
62,501
-1,978
| -3% | -$117K |
|
527
IBM
IBM
$239B
| $3.68M | ﹤0.01% |
+19,996
| New | +$3.68M |
|
|
MGLN
528
DELISTED
Magellan Health Services, Inc.
MGLN
| $3.64M | ﹤0.01% |
61,388
-5,699
| -8% | -$338K |
|
|
GNCA
529
DELISTED
Genocea Biosciences, Inc.
GNCA
| $3.64M | ﹤0.01% |
+25,000
| New | +$3.64M |
|
530
DuPont de Nemours
DD
$31.9B
| $3.57M | ﹤0.01% |
36,369
-3,261
| -8% | -$320K |
|
|
AET
531
DELISTED
Aetna Inc
AET
| $3.55M | ﹤0.01% |
47,306
-893,602
| -95% | -$67M |
|
532
Amgen
AMGN
$150B
| $3.47M | ﹤0.01% |
28,159
-20
| -0.1% | -$2.47K |
|
533
Kroger
KR
$44.3B
| $3.46M | ﹤0.01% |
158,426
-2,691,038
| -94% | -$58.7M |
|
534
Danaher
DHR
$138B
| $3.45M | ﹤0.01% |
+68,381
| New | +$3.45M |
|
|
SDRL
535
DELISTED
Seadrill Limited Common Stock
SDRL
| $3.39M | ﹤0.01% |
360
+59
| +20% | +$556K |
|
536
Whirlpool
WHR
$5.24B
| $3.35M | ﹤0.01% |
22,428
+18,142
| +423% | +$2.71M |
|
537
Encompass Health
EHC
$12.6B
| $3.34M | ﹤0.01% |
116,951
+83,937
| +254% | +$2.4M |
|
538
Intel
INTC
$116B
| $3.32M | ﹤0.01% |
128,742
-4,626,078
| -97% | -$119M |
|
539
Gyre Therapeutics
GYRE
$742M
| $3.32M | ﹤0.01% |
888
+3
| +0.3% | +$11.2K |
|
|
SUSQ
540
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $3.28M | ﹤0.01% |
287,848
-2,861
| -1% | -$32.6K |
|
|
RGLS
541
DELISTED
Regulus Therapeutics
RGLS
| $3.25M | ﹤0.01% |
3,005
+10
| +0.3% | +$10.8K |
|
542
Rockwell Automation
ROK
$38.2B
| $3.23M | ﹤0.01% |
+25,892
| New | +$3.23M |
|
543
Chevron
CVX
$318B
| $3.19M | ﹤0.01% |
26,797
+167
| +0.6% | +$19.9K |
|
544
TG Therapeutics
TGTX
$5.05B
| $3.15M | ﹤0.01% |
456,806
+1,535
| +0.3% | +$10.6K |
|
545
Berkshire Hathaway Class B
BRK.B
$1.06T
| $3.08M | ﹤0.01% |
24,660
-255
| -1% | -$31.9K |
|
546
Piper Sandler
PIPR
$5.95B
| $2.95M | ﹤0.01% |
64,291
-9,774
| -13% | -$448K |
|
547
Eli Lilly
LLY
$676B
| $2.94M | ﹤0.01% |
50,010
-18,373
| -27% | -$1.08M |
|
548
Bloomin' Brands
BLMN
$586M
| $2.85M | ﹤0.01% |
118,197
-4,397
| -4% | -$106K |
|
549
Teledyne Technologies
TDY
$25.6B
| $2.83M | ﹤0.01% |
29,025
-102,830
| -78% | -$10M |
|
550
Blackrock
BLK
$171B
| $2.78M | ﹤0.01% |
8,834
+2,800
| +46% | +$881K |
|